Clinical trial

Single Versus Combination Medication Treatment for Children With Attention…

NCT00429273 · University of California, Los Angeles, Other · Completed

Key facts

NCT number NCT00429273
Title Single Versus Combination Medication Treatment for Children With Attention Deficit Hyperactivity Disorder
Official title An Eight-Week, Randomized, Double-Blind Comparison of Guanfacine, Focalin XR, and the Combination, With a Twelve Month Open-Label Extension for the Treatment of ADHD in Pediatric Subjects Aged 7 to 14 Years
Acronym Project1
Lead sponsor University of California, Los Angeles, Other
Collaborators National Institute of Mental Health (NIMH) NIH
Status Completed
Phase Phase 4
Study type Interventional
Conditions Attention Deficit Disorder With Hyperactivity
Intervention type Drug
Interventions Guanfacine, Methylphenidate (MPH)
Enrollment 212
Start date Jan 1, 2007
Primary completion Jul 1, 2011
Completion Jul 1, 2011
First posted Jan 31, 2007
Last update posted Jul 30, 2021
Countries United States

At a glance

  • 1–9 Study sites
  • Yes Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies